Tracers / [68Ga]Ga-EMP100
[68Ga]Ga-EMP100
Also written as [68Ga]Ga-EMP100; [Ga-68]Ga-EMP100
- Radionuclide
- Ga-68 t½ 67.71 min
- Modality
- PET
- Production route
- —
- Stage
- —
- Syntheses indexed
- 1
What it is
- Compound class
- Cyclic oligopeptide conjugated to DOTA chelator (c-MET-targeting peptide)
- Target / mechanism
- c-MET (transmembrane receptor) PMID 37843660
- Clinical application
- —
- Theranostic pair
- —
Regulatory status
- FDA
- —
- EMA (centralised)
- —
- Other approvals
- —
- Brand names
- —
Clinical use
- Typical injected activity
- —
- Uptake time
- —
Reported in the literature. Not a dosing recommendation.
Published syntheses
| Module | Cassette | Purification | Yield % | RCP % | Precursor / supplier | Source |
|---|---|---|---|---|---|---|
| — Elysia-Raytest | vendor cassette | SPE | 75%, 72%, 75% no | 99.08%, 99.45%, 99.81% | EMP100 peptide Edinburgh Molecular Imaging | 37843660 2023 EJNMMI Radiopharm Chem The automated synthesis of [68Ga]Ga-EMP100 was performed on the GAIA synthesis module (Elysia Raytest, Belgium) — RCY (n.d.c.)GAIA report> 50%75%72%75% |
Need this precursor?We can point you to suppliers for [68Ga]Ga-EMP100, or handle the enquiry for you.
Get in touchQuality control Preliminary — inferred from compound class
- Ph. Eur. monograph
- —
- USP monograph
- —
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); radiometal tracer -> metal impurities (rule); Ga-68, generator production assumed (no synthesis data found) -> Ge-68 breakthrough (preliminary); receptor ligand with a saturable target -> molar activity (rule)
Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived
Setting up quality control?We can help you scope the equipment needed to release [68Ga]Ga-EMP100.
Get in touchNotes
Added from reverse module search (stage 6); 1 article(s) with Ga-68.